Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'dopamine antagonist' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 125 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Levens, N; Akins, CK
      Cocaine induces conditioned place preference and increases locomotor activity in male Japanese quail

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    2. Jaworski, JN; Gonzales, RA; Randall, PK
      Effect of dopamine D2/D3 receptor antagonist sulpiride on amphetamine-induced changes in striatal extracellular dopamine

      EUROPEAN JOURNAL OF PHARMACOLOGY
    3. Kato, M; Ishida, K; Chuma, T; Abe, K; Shigenaga, T; Taguchi, K; Miyatake, T
      beta-Phenylethylamine modulates acetylcholine release in the rat striatum:involvement of a dopamine D-2 receptor mechanism

      EUROPEAN JOURNAL OF PHARMACOLOGY
    4. Bourne, JA; Fosbraey, P; Halliday, J
      Changes in striatal electroencephalography and neurochemistry induced by kainic acid seizures are modified by dopamine receptor antagonists

      EUROPEAN JOURNAL OF PHARMACOLOGY
    5. Tachikawa, H; Suzuki, T; Kawanishi, Y; Hori, M; Hori, T; Shiraishi, H
      Tardive dystonia provoked by concomitantly administered risperidone

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    6. Kusayama, T; Watanabe, S
      Reinforcing effects of methamphetamine in planarians

      NEUROREPORT
    7. Xu, XH; Stewart, JT
      Chiral analysis of selected dopamine receptor antagonists in serum using capillary electrophoresis with cyclodextrin additives

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    8. Chaudhary, AG; McGrath, JP
      Improved synthesis of stable isotope labeled and carbon-14 labeled (S)-(-)-3-[3-(methylsulfonyl) phenyl]-1-propylpiperidine hydrochloride; (-)-OSU-6162

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    9. Matarrese, M; Soloviev, D; Moresco, RM; Todde, S; Simonelli, P; Colombo, D; Magni, F; Carpinelli, A; Fazio, F; Kienle, MG
      Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    10. Nath, C; Saxena, RC; Gupta, MB
      Effect of dopamine agonists and antagonists on the lorazepam withdrawal syndrome in rats

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    11. Wilson, AW; Costall, B; Neill, JC
      Manipulation of operant responding for an ethanol-paired conditioned stimulus in the rat by pharmacological alteration of the serotonergic system

      JOURNAL OF PSYCHOPHARMACOLOGY
    12. Anderson, KG; van Haaren, F
      Effects of SCH-23390 and raclopride on cocaine discrimination in male and female Wistar rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    13. Roelants, I; Mikolajczyk, T; Epler, P; Ollevier, F; Chyb, J; Breton, B
      Induction of spermiation in common carp after enhanced intestinal uptake of sGnRH-A and Pimozide

      JOURNAL OF FISH BIOLOGY
    14. Thompson, TL; Moore, CC; Smith, B
      Estrogen priming modulates autoreceptor-mediated potentiation of dopamine uptake

      EUROPEAN JOURNAL OF PHARMACOLOGY
    15. Barone, JA
      Formulary forum - Domperidone: A peripherally acting dopamine(2)-receptor antagonist

      ANNALS OF PHARMACOTHERAPY
    16. Mendes, MC; Ferriani, RA; Sala, MM; Moura, MD; de Sa, MF
      Induction of ovulation with clomiphene citrate in combination with metoclopramide in patients with amenorrhea of hypothalamic origin

      GYNECOLOGICAL ENDOCRINOLOGY
    17. Peacock, L; Jensen, G; Nicholson, K; Gerlach, J
      Extrapyramidal side effects during chronic combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    18. Chinen, CC; Frussa, R
      Conditioning to injection procedures and repeated testing increase SCH 23390-induced catalepsy in mice

      NEUROPSYCHOPHARMACOLOGY
    19. Mello, NK; Negus, SS
      Effects of flupenthixol and quadazocine on self-administration of speedball combinations of cocaine and heroin by rhesus monkeys

      NEUROPSYCHOPHARMACOLOGY
    20. Doan, VD; Grondin, R; Tahar, AH; Gregoire, L; Bedard, PJ
      Effect of the selective D-1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys

      CLINICAL NEUROPHARMACOLOGY
    21. Langer, O; Nagren, K; Dolle, F; Lundkvist, C; Sandell, J; Swahn, CG; Vaufrey, F; Crouzel, C; Maziere, B; Halldin, C
      Precursor synthesis and radiolabelling of the dopamine D-2 receptor ligand[C-11]raclopride from [C-11]methyl triflate

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    22. Burkey, AR; Carstens, E; Jasmin, L
      Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception

      JOURNAL OF NEUROSCIENCE
    23. Schuller, JJ; Billings, LM; Marshall, JF
      Dopaminergic modulation of pallidal preproenkephalin mRNA

      MOLECULAR BRAIN RESEARCH
    24. Stern, JM; Keer, SE
      Maternal motivation of lactating rats is disrupted by low dosages of haloperidol

      BEHAVIOURAL BRAIN RESEARCH
    25. Kashihara, K; Akiyama, K; Ishihara, T; Manabe, Y; Abe, K
      Differential regulation of AP-1 DNA-binding activity by D1 and D2 dopaminereceptor antagonists in the rat caudate-putamen and globus pallidus following a unilateral 6-OHDA lesion of the medial forebrain bundle

      NEUROLOGICAL RESEARCH
    26. Garner, KJ; Baker, LE
      Analysis of D-2 and D-3 receptor-selective ligands in rats trained to discriminate cocaine from saline

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    27. Chausmer, A; Ettenberg, A
      Intraaccumbens raclopride attenuates amphetamine-induced locomotion, but fails to prevent the response-reinstating properties of food reinforcement

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    28. Okuyama, S; Kawashima, N; Chaki, S; Yoshikawa, R; Funakoshi, T; Ogawa, S; Suzuki, Y; Ikeda, Y; Kumagai, T; Nakazato, A; Nagamine, M; Tomisawa, K
      A selective dopamine D-4 receptor antagonist, NRA0160: A preclinical neuropharmacological profile

      LIFE SCIENCES
    29. Kuczenski, R; Segal, DS
      Sensitization of amphetamine-induced stereotyped behaviors during the acute response

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    30. Sigsgaard, T; Herrstedt, J; Andersen, LJ; Havsteen, H; Langer, SW; Kjaerbol, AG; Lund, H; Kjaer, M; Dombernowsky, P
      Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy

      BRITISH JOURNAL OF CANCER
    31. Cho, S; Duchemin, AM; Neff, NH; Hadjiconstantinou, M
      Tyrosine hydroxylase, aromatic L-amino acid decarboxylase and dopamine metabolism after chronic treatment with dopaminergic drugs

      BRAIN RESEARCH
    32. Lumley, LA; Hull, EM
      Effects of a D-1 antagonist and of sexual experience on copulation-inducedFos-like immunoreactivity in the medial preoptic nucleus

      BRAIN RESEARCH
    33. Campbell, UC; Rodefer, JS; Carroll, ME
      Effects of dopamine receptor antagonists (D-1 and D-2) on the demand for smoked cocaine base in rhesus monkeys

      PSYCHOPHARMACOLOGY
    34. Peacock, L; Gerlach, J
      New and old antipsychotics versus clozapine in a monkey model: adverse effects and antiamphetamine effects

      PSYCHOPHARMACOLOGY
    35. Baldo, BA; Markou, A; Koob, GF
      Increased sensitivity to the locomotor depressant effect of a dopamine receptor antagonist during cocaine withdrawal in the rat

      PSYCHOPHARMACOLOGY
    36. SANNER MA
      SELECTIVE DOPAMINE D-4 RECEPTOR ANTAGONISTS

      Expert opinion on therapeutic patents
    37. BAKER DA; FUCHS RA; SPECIO SE; KHROYAN TV; NEISEWANDER JL
      EFFECTS OF INTRAACCUMBENS ADMINISTRATION OF SCH-23390 ON COCAINE-INDUCED LOCOMOTION AND CONDITIONED PLACE PREFERENCE

      Synapse
    38. LOPRINZI CL; PISANSKY TM; FONSECA R; SLOAN JA; ZAHASKY KM; QUELLA SK; NOVOTNY PJ; RUMMANS TA; DUMESIC DA; PEREZ EA
      PILOT EVALUATION OF VENLAFAXINE HYDROCHLORIDE FOR THE THERAPY OF HOT FLASHES IN CANCER SURVIVORS

      Journal of clinical oncology
    39. GRODUM E; ANDERSEN M; HANGAARD J; KOLDKJAER O; HAGEN C
      LACK OF EFFECT OF THE DOPAMINE D1 ANTAGONIST, NNC-01-0687, ON UNSTIMULATED AND STIMULATED RELEASE OF ANTERIOR-PITUITARY HORMONES IN MALES

      Journal of endocrinological investigation
    40. RITERS LV; ABSIL P; BALTHAZART J
      EFFECTS OF BRAIN TESTOSTERONE IMPLANTS ON APPETITIVE AND CONSUMMATORYCOMPONENTS OF MALE SEXUAL-BEHAVIOR IN JAPANESE-QUAIL

      Brain research bulletin
    41. Broderick, PA; Piercey, MF
      Neurochemical and behavioral evidence supporting (+)-AJ 76 as a potential pharmacotherapy for cocaine abuse

      JOURNAL OF NEURAL TRANSMISSION
    42. CORBIN AE; PUGSLEY TA; AKUNNE HC; WHETZEL SZ; ZOSKI KT; GEORGIC LM; NELSON CB; WRIGHT JL; WISE LD; HEFFNER TG
      PHARMACOLOGICAL CHARACTERIZATION OF PD-152255, A NOVEL DIMERIC BENZIMIDAZOLE DOPAMINE D-3 ANTAGONIST

      Pharmacology, biochemistry and behavior
    43. KATO S; MORIE T; FUJIWARA I; YOSHIDA N
      NITROGEN-CONTAINING HETEROALICYCLES WITH SEROTONIN 5-HT3 AND 5-HT4 RECEPTOR-BINDING AFFINITIES - DEVELOPMENT OF GASTROPROKINETIC AND ANTIEMETIC AGENTS

      Yuki Gosei Kagaku Kyokaishi
    44. SARRE S; VANDENEEDE D; EBINGER G; MICHOTTE Y
      BIOTRANSFORMATION OF L-DOPA TO DOPAMINE IN THE SUBSTANTIA-NIGRA OF FREELY MOVING RATS - EFFECT OF DOPAMINE-RECEPTOR AGONISTS AND ANTAGONISTS

      Journal of neurochemistry
    45. DURHAM RA; JOHNSON JD; EATON MJ; MOORE KE; LOOKINGLAND KJ
      OPPOSING ROLES FOR DOPAMINE D-1 AND D-2 RECEPTORS IN THE REGULATION OF HYPOTHALAMIC TUBEROINFUNDIBULAR DOPAMINE NEURONS

      European journal of pharmacology
    46. WILSON JM; SANYAL S; VANTOL HHM
      DOPAMINE D-2 AND D-4 RECEPTOR LIGANDS - RELATION TO ANTIPSYCHOTIC ACTION

      European journal of pharmacology
    47. MALMBERG A; MOHELL N; HOOK BB; JOHANSSON AM; HACKSELL U; NORDVALL G
      INTERACTIONS OF LIGANDS WITH ACTIVE AND INACTIVE CONFORMATIONS OF THEDOPAMINE D-2 RECEPTOR

      European journal of pharmacology
    48. Nakazato, T; Horikawa, HPM; Akiyama, A
      The dopamine D-2 receptor antagonist sulpiride causes long-lasting serotonin release

      EUROPEAN JOURNAL OF PHARMACOLOGY
    49. Weed, MR; Woolverton, WL; Paul, IA
      Dopamine D-1 and D-2 receptor selectivities of phenyl-benzazepines in rhesus monkey striata

      EUROPEAN JOURNAL OF PHARMACOLOGY
    50. PRAKASH A; WAGSTAFF AJ
      DOMPERIDONE - A REVIEW OF ITS USE IN DIABETIC GASTROPATHY

      Drugs
    51. WALSH TS; FOO IT; DRUMMOND GB; WARREN PM
      INFLUENCE OF DOSE OF DOMPERIDONE ON THE ACUTE VENTILATORY RESPONSE TOHYPOXIA IN HUMANS

      British Journal of Anaesthesia
    52. HAGINO H; TABUCHI E; KURACHI M; SAITOH O; SUN YJ; KONDOH T; ONO T; TORII K
      EFFECTS OF D-2 DOPAMINE-RECEPTOR AGONIST AND ANTAGONIST ON BRAIN ACTIVITY IN THE RAT ASSESSED BY FUNCTIONAL MAGNETIC-RESONANCE-IMAGING

      Brain research
    53. NINAN I; KULKARNI SK
      DOPAMINE-RECEPTOR SENSITIVE EFFECT OF DIZOCILPINE ON FEEDING-BEHAVIOR

      Brain research
    54. OCONNOR WT; OSBORNE PG; UNGERSTEDT U
      TOLERANCE TO CATALEPSY FOLLOWING CHRONIC HALOPERIDOL IS NOT ASSOCIATED WITH CHANGES IN GABA RELEASE IN THE GLOBUS-PALLIDUS

      Brain research
    55. DART AJ; HODGSON DR
      ROLE OF PROKINETIC DRUGS FOR TREATMENT OF POSTOPERATIVE ILEUS IN THE HORSE

      Australian Veterinary Journal
    56. Cohen, C; Perrault, G; Sanger, DJ
      Preferential involvement of D-1 versus D-2 dopamine receptors in the effects of dopamine receptor ligands on oral ethanol self administration in rats

      PSYCHOPHARMACOLOGY
    57. GLOWA JR; LESAGE M; STAFFORD D; VOCCI F
      NOVEL PHARMACOTHERAPIES FOR COCAINE ABUSE - 1995 TO PRESENT

      Expert opinion on therapeutic patents
    58. ALOK D; PILLAI D; GARG LC
      EFFECT OF D-LYS(6) SALMON SGNRH ALONE AND IN COMBINATION WITH DOMPERIDONE ON THE SPAWNING OF COMMON CARP DURING THE LATE SPAWNING SEASON

      Aquaculture international
    59. HERRSTEDT J; SIGAGAARD T; ANGELO HR; KAMPMANN JP; HANSEN M
      DOSE-FINDING STUDY OF ORAL METOPIMAZINE

      Supportive care in cancer
    60. RAJAKUMAR N; LAURIER L; NIZNIK HB; STOESSL AJ
      EFFECTS OF INTRASTRIATAL INFUSION OF D-2 RECEPTOR ANTISENSE OLIGONUCLEOTIDE ON APOMORPHINE-INDUCED BEHAVIORS IN THE RAT

      Synapse
    61. SMITH JK; NEILL JC; COSTALL B
      BIDIRECTIONAL EFFECTS OF DOPAMINE D-2 RECEPTOR ANTAGONISTS ON RESPONDING FOR A CONDITIONED REINFORCER

      Pharmacology, biochemistry and behavior
    62. WEGNER IC; DAWIRS RR; GROND C; TEUCHERTNOODT G
      DOPAMINE AND THE REGULATION OF CELL-PROLIFERATION IN GERBIL (MERIONES-UNGUICULATUS) PYLORIC MUCOSA

      Life sciences
    63. SAWAGUCHI T
      ATTENUATION OF PREPARATORY ACTIVITY FOR REACHING MOVEMENTS BY A D1-DOPAMINE ANTAGONIST IN THE MONKEY PREMOTOR CORTEX

      Journal of neurophysiology
    64. STRIEM S; BARJOSEPH A; BERKOVITCH Y; BIEGON A
      INTERACTION OF DEXANABINOL (HU-211), A NOVEL NMDA RECEPTOR ANTAGONIST, WITH THE DOPAMINERGIC SYSTEM

      European journal of pharmacology
    65. MARTIN P; WATERS N; WATERS S; CARLSSON A; CARLSSON ML
      MK-801-INDUCED HYPERLOCOMOTION - DIFFERENTIAL-EFFECTS OF M100907, SDZPSD-958 AND RACLOPRIDE

      European journal of pharmacology
    66. FEKETE MIK; HORVATH K; KEDVES R; MATE I; SZEKELY JI; SZENTKUTI E
      SELECTIVE INTERACTION OF HOMOPHTALAZINE DERIVATIVES WITH MORPHINE

      European journal of pharmacology
    67. KOBAYASHI S; OGREN SO; EBENDAL T; OLSON L
      DOPAMINE-RECEPTOR ANTAGONISTS BLOCK NERVE GROWTH FACTOR-INDUCED HYPERACTIVITY

      European journal of pharmacology
    68. HORIKAWA HPM; NAKAZATO T; HIKOSAKA O
      DURATION OF CATALEPSY CORRELATES WITH INCREASED INTRASTRIATAL SULPIRIDE

      European journal of pharmacology
    69. OKUYAMA S; CHAKI S; KAWASHIMA N; SUZUKI Y; OGAWA S; KUMAGAI T; NAKAZATO A; NAGAMINE M; YAMAGUCHI K; TOMISAWA K
      THE ATYPICAL ANTIPSYCHOTIC PROFILE OF NRA0045, A NOVEL DOPAMINE D-4 AND 5-HYDROXYTRYPTAMINE(2A) RECEPTOR ANTAGONIST, IN RATS

      British Journal of Pharmacology
    70. FOO IT; WARREN PM; DRUMMOND GB
      EFFECT OF DOMPERIDONE ON THE VENTILATORY RESPONSE TO TRANSIENT HYPEROXIA IN PATIENTS ANESTHETIZED WITH ISOFLURANE

      British Journal of Anaesthesia
    71. SOYKAN I; SAROSIEK I; MCCALLUM RW
      THE EFFECT OF CHRONIC ORAL DOMPERIDONE THERAPY ON GASTROINTESTINAL SYMPTOMS, GASTRIC-EMPTYING, AND QUALITY-OF-LIFE IN PATIENTS WITH GASTROPARESIS

      The American journal of gastroenterology
    72. CONTI LH; SEGAL DS; KUCZENSKI R
      MAINTENANCE OF AMPHETAMINE-INDUCED STEREOTYPY AND LOCOMOTION REQUIRESONGOING DOPAMINE-RECEPTOR ACTIVATION

      Psychopharmacology
    73. LOCH C; HALLDIN C; BOTTLAENDER M; SWAHN CG; MORESCO RM; MAZIERE M; FARDE L; MAZIERE B
      PREPARATION OF [BR-76]FLB-457 AND [BR-76]FLB-463 FOR EXAMINATION OF STRIATAL AND EXTRASTRIATAL DOPAMINE D-2 RECEPTORS WITH PET

      Nuclear medicine and biology
    74. FOGED C; HALLDIN C; LOCH C; MAZIERE B; KARLSSON P; MAZIERE M; SWAHN CG; FARDE L
      C-11-LABELED AND BR-76-LABELED NNC-22-0010, SELECTIVE DOPAMINE D-1 RECEPTOR RADIOLIGANDS FOR PET

      Nuclear medicine and biology
    75. TAKEUCHI Y; MATSUKAWA T; SUGIYAMA Y; IWASE S; MANO T
      EFFECT OF METOCLOPRAMIDE ON MUSCLE SYMPATHETIC-NERVE ACTIVITY IN HUMANS

      Journal of the autonomic nervous system
    76. PARSONS LH; CAINE SB; SOKOLOFF P; SCHWARTZ JC; KOOB GF; WEISS F
      NEUROCHEMICAL EVIDENCE THAT POSTSYNAPTIC NUCLEUS-ACCUMBENS D-3 RECEPTOR STIMULATION ENHANCES COCAINE REINFORCEMENT

      Journal of neurochemistry
    77. ITO K; NAKAZAWA K; KOIZUMI S; LIU M; TAKEUCHI K; HASHIMOTO T; OHNO Y; INOUE K
      INHIBITION BY ANTIPSYCHOTIC-DRUGS OF L-TYPE CA2+ CHANNEL CURRENT IN PC12 CELLS

      European journal of pharmacology
    78. ZARRINDAST MR; SHARIFZADEH M; SADEGHI AI
      THEOPHYLLINE-INDUCED GROOMING - POSSIBLE INDIRECT DOPAMINERGIC MECHANISM

      European journal of pharmacology
    79. ZARRINDAST MR; FARZIN D
      NICOTINE ATTENUATES NALOXONE-INDUCED JUMPING BEHAVIOR IN MORPHINE-DEPENDENT MICE

      European journal of pharmacology
    80. SARRE S; EBINGER G; MICHOTTE Y
      LEVODOPA BIOTRANSFORMATION IN HEMI-PARKINSON RATS - EFFECT OF DOPAMINE-RECEPTOR AGONISTS AND ANTAGONISTS

      European journal of pharmacology
    81. KAFKA SH; CORBETT R
      SELECTIVE ADENOSINE A(2A) RECEPTOR DOPAMINE D-2 RECEPTOR INTERACTIONSIN ANIMAL-MODELS OF SCHIZOPHRENIA

      European journal of pharmacology
    82. KOSTEN TA; DECAPRIO JL; NESTLER EJ
      LONG-TERM HALOPERIDOL ADMINISTRATION ENHANCES AND SHORT-TERM ADMINISTRATION ATTENUATES THE BEHAVIORAL-EFFECTS OF COCAINE IN A PLACE CONDITIONING PROCEDURE

      Psychopharmacology
    83. WARD AS; LI DH; LUEDTKE RR; EMMETTOGLESBY MW
      VARIATIONS IN COCAINE SELF-ADMINISTRATION BY INBRED RAT STRAINS UNDERA PROGRESSIVE-RATIO SCHEDULE

      Psychopharmacology
    84. BYMASTER FP; HEMRICKLUECKE SK; PERRY KW; FULLER RW
      NEUROCHEMICAL EVIDENCE FOR ANTAGONISM BY OLANZAPINE OF DOPAMINE, SEROTONIN, ALPHA(1)-ADRENERGIC AND MUSCARINIC RECEPTORS IN-VIVO IN RATS

      Psychopharmacology
    85. KLINGPETERSEN T; LJUNG E; WOLLTER L; SVENSSON K
      EFFECTS OF THE DOPAMINE D3-AND AUTORECEPTOR PREFERRING ANTAGONIST (-)-DS121 ON LOCOMOTOR-ACTIVITY, CONDITIONED PLACE PREFERENCE AND INTRACRANIAL SELF-STIMULATION IN THE RAT

      Behavioural pharmacology
    86. SEKI K; MITSUI C; NAGATA I
      EFFECTS OF A DOPAMINE ANTAGONIST (METOCLOPRAMIDE) ON THE RELEASE OF BETA-ENDORPHIN, ACTH AND CORTISOL IN HYPERPROLACTINEMIC-AMENORRHEIC WOMEN

      Gynecologic and obstetric investigation
    87. COLE HW; BROWN CE; MAGEE DE; MAGEE C; ROUDEBUSH RE; BRYANT HU
      SEROTONIN-INDUCED PAW EDEMA IN THE RAT - PHARMACOLOGICAL PROFILE

      General pharmacology
    88. MUKHERJEE M; CHATTERJEE S; PAKRASHI A; GHOSH A
      ADRENAL-GLAND RESPONSES TO A DOPAMINE ANTAGONIST IN RAT

      Biogenic amines
    89. LAPIN IP; ROGAWSKI MA
      EFFECTS OF D1 AND D2 DOPAMINE-RECEPTOR ANTAGONISTS AND CATECHOLAMINE DEPLETING AGENTS ON THE LOCOMOTOR STIMULATION-INDUCED BY DIZOCILPINE IN MICE

      Behavioural brain research
    90. KURIBARA H
      DOPAMINE D-1 RECEPTOR ANTAGONIST SCH-23390 RETARDS METHAMPHETAMINE SENSITIZATION IN BOTH COMBINED ADMINISTRATION AND EARLY POSTTREATMENT SCHEDULES IN MICE

      Pharmacology, biochemistry and behavior
    91. OZAKI M; MIYAMOTO Y; KISHIOKA S; MASUDA Y; YAMAMOTO H
      THE DOPAMINERGIC SYSTEM MODULATES THE ENDOGENOUS OPIOID SYSTEM IN GUINEA-PIG ISOLATED ILEAL LONGITUDINAL MUSCLE

      Neuropharmacology
    92. SUZUKI T; MISAWA M
      SERTINDOLE ANTAGONIZES MORPHINE-INDUCED, COCAINE-INDUCED, AND METHAMPHETAMINE-INDUCED PLACE PREFERENCE IN THE RAT

      Life sciences
    93. YONEZAWA Y; KUROKI T; TASHIRO N; HONDO H; UCHIMURA H
      POTENTIATION OF PHENCYCLIDINE-INDUCED DOPAMINE RELEASE IN THE RAT STRIATUM BY THE BLOCKADE OF DOPAMINE D-2 RECEPTOR

      European journal of pharmacology
    94. EMADUDDIN M; LIU GJ; TAKEUCHI H
      EFFECTS OF DOPAMINE ON SNAIL NEURONS

      European journal of pharmacology
    95. CLARK D; EXNER M; FURMIDGE LJ; SVENSSON K; SONESSON C
      EFFECTS OF THE DOPAMINE AUTORECEPTOR ANTAGONIST (-)-DS121 ON THE DISCRIMINATIVE STIMULUS PROPERTIES OF D-AMPHETAMINE AND COCAINE

      European journal of pharmacology
    96. FOO IT; MARTIN SE; LEE RJ; DRUMMOND GB; WARREN PM
      INTERACTION OF THE EFFECTS OF DOMPERIDONE AND SUB-ANESTHETIC CONCENTRATIONS OF ISOFLURANE ON THE IMMEDIATE AND SUSTAINED HYPOXIC VENTILATORY RESPONSE IN HUMANS

      British Journal of Anaesthesia
    97. WIRTSHAFTER D; ASIN KE
      DOPAMINE ANTAGONISTS INDUCE FOS-LIKE-IMMUNOREACTIVITY IN THE SUBSTANTIA-NIGRA AND ENTOPEDUNCULAR NUCLEUS OF THE RAT

      Brain research
    98. SKRUMSAGER BK; CHRISTENSEN JV; SNEL S; SEIBERLING M
      TOLERABILITY, SAFETY AND PHARMACOKINETICS OF SINGLE-DOSE AND MULTIPLEDOSING OF THE SELECTIVE D1 ANTAGONIST NNC-01-0687 IN HEALTHY-SUBJECTS

      Psychopharmacology
    99. KARLSSON P; SMITH L; FARDE L; HARNRYD C; SEDVALL G; WIESEL FA
      LACK OF APPARENT ANTIPSYCHOTIC EFFECT OF THE D-1-DOPAMINE RECEPTOR ANTAGONIST SCH39166 IN ACUTELY ILL SCHIZOPHRENIC-PATIENTS

      Psychopharmacology
    100. MOLEWIJK HE; VANDERPOEL AM; MOS J; VANDERHEYDEN JAM; OLIVIER B
      CONDITIONED ULTRASONIC DISTRESS VOCALIZATIONS IN ADULT MALE-RATS AS ABEHAVIORAL PARADIGM FOR SCREENING ANTI-PANIC DRUGS

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 19:52:06